ANN ARBOR, Mich., Oct. 25 /PRNewswire/ -- Adeona Pharmaceuticals, Inc., (Amex: AEN) announced today that its Chief Executive Officer, James S. Kuo, M.D., M.B.A., will provide the keynote address at the Emerging Biosciences Showcase during the 2010 MichBio Expo & Conference.
The 2010 MichBio Expo & Conference will take place at the Ann Arbor Marriott Ypsilanti at Eagle Crest on October 26 and 27. The event is Michigan‘s premiere event for the biosciences industry and brings together bioscience professionals. More information on the conference is available at www.michbio.org/expo.
Dr. Kuo’s keynote address is entitled “How to raise early-stage financings, a first-hand account of life in the trenches.” It is scheduled to occur on Tuesday, October 26, at 12:15 p.m. in Auditorium 1.
Additionally, Dr. Kuo will be one of the presenters in the panel discussion “Ag/Bio-based Technologies: Swallowing Health: Convergence of Food, Nutrition and Pharma,” where he will discuss the area of medical foods. The panel discussion is scheduled for Wednesday, October 27, at 9:15 a.m. in Conference Room B.
MichBio is Michigan‘s trade association for the biosciences industry and strives to be its recognized voice, as well as its foremost source of education, information and services. Its members represent the pharmaceutical, medical devices, diagnostics, biotech, informatics and clinical research sub-sectors. MichBio is the state affiliate of the Biotechnology Industry Organization.
About Adeona Pharmaceuticals, Inc.
Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Our primary strategy is to license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to a valuation inflection point resulting in a significant development and marketing collaboration. We have four drug candidates and one medical food candidate in development. Further information on the company is available at www.adeonapharma.com.
SOURCE Adeona Pharmaceuticals, Inc.
